Insiders · CLVS

CLVS insider transactions

Clovis Oncology Inc. (CLVS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

CLVS insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Clovis Oncology Inc., latest first. Follow anyone to get their next filing.

• Lindsey RolfeOfficer-$200K
• Paul Edward GrossOfficer-$204K
• Gillian C Ivers-ReadOfficer-$183K
• Thomas C. HardingOfficer, since December 2020-$157K
• Daniel W MuehlOfficer-$203K
• Patrick J MahaffyOfficer, Director
• Ronit SimantovDirector, since July 2021
• Thorlef SpickschenDirector
• Robert AzelbyDirector
• Paul H KlingensteinDirector
• James C BlairDirector
• Keith T. FlahertyDirector
• Edward J McKinleyDirector
• Ginger L GrahamDirector
• Brian G AtwoodDirector
• Richard A. FairDirector

Recent Form 3, 4, and 5 filings for CLVS

• 1470d
  SEC Form 4: Rolfe Lindsey converted options into 8,374 shares and sold $4,188 worth of shares (4,261 units at $0.98), increasing direct ownership by 4% to 113,691 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1470d
  SEC Form 4: Gross Paul Edward converted options into 10,248 shares and sold $4,649 worth of shares (4,730 units at $0.98), increasing direct ownership by 6% to 98,330 units (for tax liability)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1470d
  SEC Form 4: Muehl Daniel W converted options into 10,248 shares and sold $4,501 worth of shares (4,579 units at $0.98), increasing direct ownership by 6% to 104,830 units to cover withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1470d
  SEC Form 4: Harding Thomas C. sold $1,736 worth of shares (1,766 units at $0.98) and converted options into 3,555 shares, increasing direct ownership by 9% to 19,487 units to satisfy tax liability

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1470d
  SEC Form 4: Ivers-Read Gillian C converted options into 8,374 shares and sold $3,618 worth of shares (3,681 units at $0.98), increasing direct ownership by 2% to 293,612 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1500d
  SEC Form 4: Harding Thomas C. converted options into 15 shares and sold $8 worth of shares (6 units at $1.29) (withholding obligation)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1528d
  SEC Form 4: Gross Paul Edward converted options into 5,063 shares and sold $2,770 worth of shares (2,308 units at $1.20), increasing direct ownership by 3% to 92,812 units to satisfy tax liability

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1528d
  SEC Form 4: Harding Thomas C. sold $1,939 worth of shares (1,616 units at $1.20) and converted options into 3,404 shares, increasing direct ownership by 9% to 17,816 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1528d
  SEC Form 4: Rolfe Lindsey converted options into 5,063 shares and sold $3,054 worth of shares (2,545 units at $1.20), increasing direct ownership by 2% to 109,578 units to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1528d
  SEC Form 4: Muehl Daniel W converted options into 5,063 shares and sold $2,681 worth of shares (2,234 units at $1.20), increasing direct ownership by 3% to 99,161 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1528d
  SEC Form 4: Ivers-Read Gillian C converted options into 5,063 shares and sold $2,681 worth of shares (2,234 units at $1.20), increasing direct ownership by 0.99% to 288,919 units to cover taxes

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1562d
  SEC Form 4: Muehl Daniel W converted options into 10,249 shares and sold $6,799 worth of shares (4,654 units at $1.46), increasing direct ownership by 6% to 96,332 units (tax liability)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1562d
  SEC Form 4: Gross Paul Edward sold $7,024 worth of shares (4,807 units at $1.46) and converted options into 10,249 shares, increasing direct ownership by 6% to 90,057 units (withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1562d
  SEC Form 4: Ivers-Read Gillian C converted options into 8,374 shares and sold $5,555 worth of shares (3,802 units at $1.46), increasing direct ownership by 2% to 286,090 units (for withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1562d
  SEC Form 4: Rolfe Lindsey sold $6,326 worth of shares (4,330 units at $1.46) and converted options into 8,374 shares, increasing direct ownership by 4% to 107,060 units (for tax liability)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1562d
  SEC Form 4: Harding Thomas C. converted options into 3,557 shares and sold $2,643 worth of shares (1,809 units at $1.46), increasing direct ownership by 11% to 16,364 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1590d
  SEC Form 4: Harding Thomas C. converted options into 16 shares and sold $19 worth of shares (7 units at $2.71) to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1623d
  SEC Form 4: Harding Thomas C. converted options into 3,403 shares and sold $1,106 worth of shares (1,722 units at $0.64), increasing direct ownership by 10% to 14,720 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1623d
  SEC Form 4: Rolfe Lindsey sold $1,703 worth of shares (2,650 units at $0.64) and converted options into 5,062 shares, increasing direct ownership by 2% to 103,016 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1623d
  SEC Form 4: Muehl Daniel W converted options into 5,062 shares and sold $1,495 worth of shares (2,327 units at $0.64), increasing direct ownership by 3% to 90,737 units to satisfy tax liability

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1623d
  SEC Form 4: Gross Paul Edward converted options into 5,062 shares and sold $1,544 worth of shares (2,403 units at $0.64), increasing direct ownership by 3% to 84,615 units to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1623d
  SEC Form 4: Ivers-Read Gillian C converted options into 5,062 shares and sold $1,495 worth of shares (2,327 units at $0.64), increasing direct ownership by 0.98% to 281,518 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1654d
  SEC Form 4: Ivers-Read Gillian C converted options into 8,374 shares and sold $7,353 worth of shares (3,733 units at $1.97), increasing direct ownership by 2% to 278,783 units to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1654d
  SEC Form 4: Muehl Daniel W converted options into 10,248 shares and sold $9,002 worth of shares (4,570 units at $1.97), increasing direct ownership by 7% to 88,002 units to cover withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1654d
  SEC Form 4: Rolfe Lindsey converted options into 8,374 shares and sold $8,376 worth of shares (4,252 units at $1.97), increasing direct ownership by 4% to 100,604 units (withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1654d
  SEC Form 4: Harding Thomas C. converted options into 3,555 shares and sold $3,498 worth of shares (1,776 units at $1.97), increasing direct ownership by 14% to 13,328 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1654d
  SEC Form 4: Gross Paul Edward converted options into 10,248 shares and sold $9,002 worth of shares (4,570 units at $1.97), increasing direct ownership by 7% to 81,956 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1682d
  SEC Form 4: Harding Thomas C. converted options into 16 shares and sold $19 worth of shares (7 units at $2.66) to cover taxes

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1715d
  SEC Form 4: Rolfe Lindsey sold $20,423 worth of shares (10,945 units at $1.87) and converted options into 20,938 shares, increasing direct ownership by 12% to 96,482 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1715d
  SEC Form 4: Gross Paul Edward converted options into 20,813 shares and sold $19,977 worth of shares (10,706 units at $1.87), increasing direct ownership by 15% to 76,278 units to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1715d
  SEC Form 4: Muehl Daniel W converted options into 20,813 shares and sold $19,977 worth of shares (10,706 units at $1.87), increasing direct ownership by 14% to 82,324 units (for tax liability)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1715d
  SEC Form 4: Harding Thomas C. converted options into 13,916 shares and sold $14,603 worth of shares (7,826 units at $1.87), increasing direct ownership by 73% to 11,654 units to satisfy tax liability

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1715d
  SEC Form 4: Ivers-Read Gillian C converted options into 20,938 shares and sold $20,097 worth of shares (10,770 units at $1.87), increasing direct ownership by 4% to 274,142 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1715d
  SEC Form 4 filed by Mahaffy Patrick J

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1743d
  SEC Form 4: Rolfe Lindsey sold $8,756 worth of shares (4,514 units at $1.94) and converted options into 8,375 shares, increasing direct ownership by 5% to 86,489 units to cover withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1743d
  SEC Form 4: Ivers-Read Gillian C converted options into 8,375 shares and sold $8,616 worth of shares (4,442 units at $1.94), increasing direct ownership by 2% to 263,974 units to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1743d
  SEC Form 4: Muehl Daniel W converted options into 10,250 shares and sold $10,544 worth of shares (5,436 units at $1.94), increasing direct ownership by 7% to 72,217 units (withholding obligation)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1743d
  SEC Form 4: Harding Thomas C. converted options into 3,558 shares and sold $4,108 worth of shares (2,118 units at $1.94), increasing direct ownership by 25% to 6,734 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1743d
  SEC Form 4: Gross Paul Edward converted options into 10,250 shares and sold $10,544 worth of shares (5,436 units at $1.94), increasing direct ownership by 8% to 66,171 units (withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1773d
  SEC Form 4: Harding Thomas C. converted options into 16 shares and sold $19 worth of shares (7 units at $2.75) to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1805d
  SEC Form 4: Muehl Daniel W converted options into 562 shares and sold $744 worth of shares (248 units at $3.00), increasing direct ownership by 0.47% to 67,403 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1805d
  SEC Form 4: Rolfe Lindsey converted options into 687 shares and sold $1,038 worth of shares (346 units at $3.00), increasing direct ownership by 0.41% to 82,628 units (withholding obligation)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1805d
  SEC Form 4: Harding Thomas C. converted options into 299 shares and sold $444 worth of shares (148 units at $3.00), increasing direct ownership by 3% to 5,395 units to satisfy tax liability

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1805d
  SEC Form 4: Ivers-Read Gillian C converted options into 687 shares and sold $912 worth of shares (304 units at $3.00), increasing direct ownership by 0.15% to 260,041 units (withholding obligation)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1805d
  SEC Form 4: Gross Paul Edward converted options into 562 shares and sold $744 worth of shares (248 units at $3.00), increasing direct ownership by 0.51% to 61,357 units (for withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1835d
  SEC Form 4: Ivers-Read Gillian C sold $16,817 worth of shares (3,696 units at $4.55) and converted options into 8,374 shares, increasing direct ownership by 2% to 259,658 units (for withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1835d
  SEC Form 4: Rolfe Lindsey converted options into 8,374 shares and sold $19,151 worth of shares (4,209 units at $4.55), increasing direct ownership by 5% to 82,287 units (for withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1835d
  SEC Form 4: Muehl Daniel W converted options into 10,248 shares and sold $20,580 worth of shares (4,523 units at $4.55), increasing direct ownership by 9% to 67,089 units to satisfy withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1835d
  SEC Form 4: Gross Paul Edward converted options into 10,248 shares and sold $20,580 worth of shares (4,523 units at $4.55), increasing direct ownership by 10% to 61,043 units to satisfy withholding obligation

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1835d
  SEC Form 4: Harding Thomas C. converted options into 3,555 shares and sold $7,935 worth of shares (1,744 units at $4.55), increasing direct ownership by 47% to 5,255 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1864d
  SEC Form 4: Harding Thomas C. converted options into 15 shares and sold $26 worth of shares (6 units at $4.41) (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1896d
  SEC Form 4: Harding Thomas C. converted options into 300 units of Common Stock and sold $724 worth of Common Stock (148 units at $4.89), increasing direct ownership by 4% to 3,563 units (tax withholding)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1896d
  SEC Form 4: Ivers-Read Gillian C sold $1,487 worth of Common Stock (304 units at $4.89) and converted options into 688 units of Common Stock, increasing direct ownership by 0.15% to 254,980 units (for tax liability)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1896d
  SEC Form 4: Muehl Daniel W sold $1,218 worth of Common Stock (249 units at $4.89) and converted options into 563 units of Common Stock, increasing direct ownership by 0.51% to 61,364 units (withholding obligation)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1896d
  SEC Form 4: Rolfe Lindsey converted options into 688 units of Common Stock and sold $1,697 worth of Common Stock (347 units at $4.89), increasing direct ownership by 0.44% to 78,122 units (withholding obligation)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1896d
  SEC Form 4: Gross Paul Edward converted options into 563 units of Common Stock and sold $1,218 worth of Common Stock (249 units at $4.89), increasing direct ownership by 0.57% to 55,318 units (withholding tax)

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1948d
  SEC Form 4 filed by Simantov Ronit

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1948d
  SEC Form 3 filed by Simantov Ronit

  3 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1955d
  SEC Form 4: Harding Thomas C. converted options into 63 units of Common Stock and sold $151 worth of Common Stock (26 units at $5.79) to cover withholding tax

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)
• 1979d
  SEC Form 4 filed by SPICKSCHEN THORLEF

  4 - Clovis Oncology, Inc. (0001466301) (Issuer)